Related Articles
Molecular mechanisms of lung‑specific toxicity induced by epidermal growth factor receptor tyrosine kinase inhibitors (Review)
Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non‑small cell lung cancer (Review)
Tyrosine kinase inhibitors in breast cancer (Review)
Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation (Review)
Cotargeting EGFR and autophagy signaling: A novel therapeutic strategy for non‑small‑cell lung cancer (Review)